These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28833211)

  • 61. Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages.
    Kuroda S; Nishio M; Sasaki T; Horie Y; Kawahara K; Sasaki M; Natsui M; Matozaki T; Tezuka H; Ohteki T; Förster I; Mak TW; Nakano T; Suzuki A
    Eur J Immunol; 2008 May; 38(5):1331-40. PubMed ID: 18398930
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice.
    Maillard I; Launois P; Himmelrich H; Acha-Orbea H; Diggelmann H; Locksley RM; Louis JA
    Eur J Immunol; 2001 Apr; 31(4):1288-96. PubMed ID: 11298356
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Repeated intravenous injection of adipose tissue derived mesenchymal stem cells enhances Th1 immune responses in Leishmania major-infected BALB/c mice.
    Zanganeh E; Soudi S; Zavaran Hosseini A; Khosrojerdi A
    Immunol Lett; 2019 Dec; 216():97-105. PubMed ID: 31622634
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment with synthetic lipophilic tyrosyl ester controls Leishmania major infection by reducing parasite load in BALB/c mice.
    Sghaier RM; Aissa I; Attia H; Bali A; Leon Martinez PA; Mkannez G; Guerfali FZ; Gargouri Y; Laouini D
    Parasitology; 2016 Oct; 143(12):1615-21. PubMed ID: 27312247
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production.
    Li J; Sutterwala S; Farrell JP
    Infect Immun; 1997 Aug; 65(8):3225-30. PubMed ID: 9234779
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model.
    Heidari-Kharaji M; Taheri T; Doroud D; Habibzadeh S; Badirzadeh A; Rafati S
    Parasite Immunol; 2016 Oct; 38(10):599-608. PubMed ID: 27213964
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.
    Muleme HM; Reguera RM; Berard A; Azinwi R; Jia P; Okwor IB; Beverley S; Uzonna JE
    J Immunol; 2009 Dec; 183(12):8068-76. PubMed ID: 19923451
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sambucus ebulus extract stimulates cellular responses in cutaneous leishmaniasis.
    Heidari-Kharaji M; Fallah-Omrani V; Badirzadeh A; Mohammadi-Ghalehbin B; Nilforoushzadeh MA; Masoori L; Montakhab-Yeganeh H; Zare M
    Parasite Immunol; 2019 Jan; 41(1):e12605. PubMed ID: 30472741
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major.
    Zaph C; Scott P
    Infect Immun; 2003 Mar; 71(3):1587-9. PubMed ID: 12595483
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica.
    Nahidi S; Gholami E; Taslimi Y; Habibzadeh S; Seyed N; Davarpanah E; Ghanadan A; Rafati S; Taheri T
    Parasite Immunol; 2020 Mar; 42(3):e12691. PubMed ID: 31811772
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Therapeutic Effects of Curcumin-coated Gold Nanoparticle Against Leishmania Major Causative Agent of Zoonotic Cutaneous Leishmaniasis (ZCL): An In Vitro and In Vivo Study.
    Amini SM; Hadighi R; Najm M; Alipour M; Hasanpour H; Vosoogh M; Vosough A; Hajizadeh M; Badirzadeh A
    Curr Microbiol; 2023 Feb; 80(4):104. PubMed ID: 36781499
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library.
    Rhaiem RB; Houimel M
    Acta Trop; 2016 Jul; 159():11-9. PubMed ID: 26995695
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 5-ALA-mediated photodynamic therapy reduces the parasite load in mice infected with Leishmania braziliensis.
    Souza DM; Alves PM; Silva ML; Paulino TP; Coraspe HO; Mendonça MM; Ribeiro BM; da Silva MV; Rodrigues Júnior V; Rodrigues DB
    Parasite Immunol; 2017 Mar; 39(3):. PubMed ID: 27886396
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Olive (Olea europaea) leaf extract alters the cytokine profile of Leishmania major-infected macrophages: New insight into the underlying mechanism.
    Kheirandish F; Mosaffa N; Tarahi MJ; Fallahi S
    Parasite Immunol; 2018 Apr; 40(4):e12520. PubMed ID: 29450889
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion.
    Mou Z; Muleme HM; Liu D; Jia P; Okwor IB; Kuriakose SM; Beverley SM; Uzonna JE
    J Immunol; 2013 Apr; 190(7):3380-9. PubMed ID: 23460745
    [TBL] [Abstract][Full Text] [Related]  

  • 78. L-arginine deprivation impairs Leishmania major-specific T-cell responses.
    Munder M; Choi BS; Rogers M; Kropf P
    Eur J Immunol; 2009 Aug; 39(8):2161-72. PubMed ID: 19637195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of tropism and virulence of Leishmania parasites on cytokine production by infected human monocytes.
    Meddeb-Garnaoui A; Zrelli H; Dellagi K
    Clin Exp Immunol; 2009 Feb; 155(2):199-206. PubMed ID: 19040614
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Naloxone Diminishes the Virulence and Modifies the Cellular Immune Responses of BALB/c Mice Infected with Leishmania major.
    Alimohammadian MH; Riazi-Rad F; Asadi-Tat M; Darabi S; Darabi H; Khaze V; Bahrami F; Ajdary S
    Acta Parasitol; 2021 Jun; 66(2):517-523. PubMed ID: 33211271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.